F. Porteu
发表
C. Nathan,
A. Ding,
F. Porteu,
1990,
Science.
C. Preudhomme,
C. Lacombe,
F. Porteu,
2005,
Leukemia.
F. Porteu,
G. Courtois,
S. Chrétien,
2002,
The Journal of Biological Chemistry.
Rajiv Kumar,
V. Baud,
F. Porteu,
2014,
Blood.
Rajiv Kumar,
V. Baud,
F. Porteu,
2014
.
F. Porteu,
M. Souyri,
F. Pouzoulet,
2013,
Cell stem cell.
I. Dusanter-Fourt,
F. Porteu,
L. Benit,
1996,
Molecular and cellular biology.
I. Dusanter-Fourt,
A. Doubeikovski,
F. Porteu,
1997,
The Journal of Biological Chemistry.
P. Rieu,
F. Porteu,
L. Halbwachs‐Mecarelli,
1992,
European journal of immunology.
A. Ding,
F. Porteu,
1992,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
I. Dusanter-Fourt,
C. Lacombe,
F. Porteu,
2001,
Oncogene.
C. Nathan,
A. Ding,
F. Porteu,
1990,
The Journal of experimental medicine.
E. Bruyneel,
P. Romeo,
F. Porteu,
2005,
Oncogene.
F. Porteu,
P. Mayeux,
S. Chrétien,
2003,
The Journal of Biological Chemistry.
F. Porteu,
Emilie Elvira-Matelot,
M. Diop,
2022,
The Journal of experimental medicine.
C. Nathan,
D. Wallach,
M. Brockhaus,
1991,
The Journal of biological chemistry.
F. Porteu,
C. Hieblot,
1994,
The Journal of biological chemistry.
F. Porteu,
M. Souyri,
S. Gisselbrecht,
2000,
Oncogene.
M. Dougados,
F. Porteu,
L. Halbwachs‐Mecarelli,
1995,
Clinical and experimental immunology.
R. Tomasini,
J. Iovanna,
G. Lomberk,
2022
.
F. Porteu,
M. Fontenay,
E. Gyan,
2006,
Leukemia.
F. Porteu,
L. Halbwachs‐Mecarelli,
A. Mir,
1987,
European journal of immunology.
P. Romeo,
F. Porteu,
M. Gaudry,
2011
.
P. Romeo,
F. Porteu,
M. Gaudry,
2006,
Blood.
W. Vainchenker,
F. D. de Sauvage,
F. Porteu,
2002,
Blood.
ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response
I. Leray,
R. Kumar,
F. Rosselli,
2010,
Cell Death and Differentiation.
Mei X. Wu,
Yujin Zhang,
Prasad Kanteti,
2003,
Oncogene.
J. Pouysségur,
G. Pagès,
X. Holy,
2012,
PloS one.
W. Vainchenker,
N. Debili,
F. D. de Sauvage,
2000,
Experimental hematology.
I. Dusanter-Fourt,
F. Porteu,
P. Mayeux,
1995,
Blood.
C. Nathan,
F. Porteu,
1992,
Journal of leukocyte biology.
C. Deswarte,
E. Pasmant,
I. Laurendeau,
2014,
Oncogene.
F. Porteu,
Claire Letourneux,
Géraldine Rocher,
2006,
The EMBO journal.
I. Dusanter-Fourt,
F. Porteu,
M. Rouyez,
1997,
Molecular and cellular biology.
P. Lenormand,
F. Porteu,
Claire Letourneux,
2007,
Journal of Biological Chemistry.
IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
R. Tomasini,
J. Iovanna,
G. Lomberk,
2014,
The Journal of clinical investigation.
D. Gautheret,
E. Pronier,
E. Solary,
2022,
Communications Biology.
F. Porteu,
G. Pézeron,
V. Arranz,
2002,
The EMBO journal.
F. Porteu,
F. Picard,
S. Fichelson,
1999
.
F. Porteu,
F. Picard,
S. Fichelson,
1999,
Blood.
J. de Gunzburg,
A. Eychène,
F. Porteu,
2001,
Molecular and Cellular Biology.
C. Pecquet,
S. Constantinescu,
F. Porteu,
2018,
The Journal of experimental medicine.
P. Opolon,
J. Pouysségur,
G. Pagès,
2010,
Blood.
C. Nathan,
F. Porteu,
FranyoisePorteuand Carl Nathan,
1990,
The Journal of experimental medicine.
F. Porteu,
Emilie Elvira-Matelot,
M. Diop,
2022,
bioRxiv.
F. Porteu,
Emilie Elvira-Matelot,
M. Diop,
2021
.
M. Pangburn,
F. Porteu,
A. Calender,
1990,
European journal of immunology.
A. Baruchel,
J. Gross,
C. Deswarte,
2014,
EMBO molecular medicine.
V. Viallon,
F. Porteu,
E. Frisan,
2010,
Haematologica.
P. Romeo,
F. Porteu,
D. Duménil,
2009,
Stem cells.
V. Vanneaux,
I. Naguibneva,
F. Porteu,
2016,
Stem cell reports.
O. Abdel-Wahab,
E. Solary,
W. Vainchenker,
2023,
Leukemia.
F. Porteu,
P. Mayeux,
S. Chrétien,
2003,
The Journal of Biological Chemistry.
A. Fischer,
F. Porteu,
B. Descamps-Latscha,
1986,
Clinical and Experimental Immunology.
C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
F. Porteu,
L. Halbwachs‐Mecarelli,
P. Lesavre,
1988,
Clinical and experimental immunology.
E. Solary,
P. Fenaux,
S. Thépot,
2020,
Blood.
F. Porteu,
M. Souyri,
F. Pouzoulet,
2013,
Cell stem cell.